The Anxiolytic Actions of 2-Arachidonoylglycerol: Converging Evidence From Two Recent Genetic Endocannabinoid Deficiency Models

Affiliations

• ¹ Departments of Psychiatry, Vanderbilt University School of Medicine, Nashville, Tennessee; Molecular Physiology and Biophysics, Vanderbilt University School of Medicine, Nashville, Tennessee; Vanderbilt Brain Institute, Vanderbilt University School of Medicine, Nashville, Tennessee; Vanderbilt-Kennedy Center for Research on Human Development, Vanderbilt University School of Medicine, Nashville, Tennessee. Electronic address: sachin.patel@vanderbilt.edu.
• ² Molecular Physiology and Biophysics, Vanderbilt University School of Medicine, Nashville, Tennessee.
• ³ Departments of Psychiatry, Vanderbilt University School of Medicine, Nashville, Tennessee.
• ⁴ Departments of Psychiatry, Vanderbilt University School of Medicine, Nashville, Tennessee; Molecular Physiology and Biophysics, Vanderbilt University School of Medicine, Nashville, Tennessee; Vanderbilt Brain Institute, Vanderbilt University School of Medicine, Nashville, Tennessee; Vanderbilt-Kennedy Center for Research on Human Development, Vanderbilt University School of Medicine, Nashville, Tennessee.
• ⁵ Molecular Physiology and Biophysics, Vanderbilt University School of Medicine, Nashville, Tennessee; Vanderbilt Brain Institute, Vanderbilt University School of Medicine, Nashville, Tennessee; Vanderbilt-Kennedy Center for Research on Human Development, Vanderbilt University School of Medicine, Nashville, Tennessee.